Gary L. C. Chan

453 total citations
14 papers, 327 citations indexed

About

Gary L. C. Chan is a scholar working on Transplantation, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Gary L. C. Chan has authored 14 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 5 papers in Public Health, Environmental and Occupational Health and 2 papers in Molecular Biology. Recurrent topics in Gary L. C. Chan's work include Renal Transplantation Outcomes and Treatments (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Biochemical and Molecular Research (2 papers). Gary L. C. Chan is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Biochemical and Molecular Research (2 papers). Gary L. C. Chan collaborates with scholars based in United States. Gary L. C. Chan's co-authors include Daniel M. Canafax, Scott A. Gruber, Gary R. Erdmann, Arthur J. Matas, Gary R. Matzke, Curtis A. Johnson, D. M. Canafax, Saskia Gruber, A. J. Matas and Dana L. Shires and has published in prestigious journals such as Journal of the American Academy of Dermatology, Transplantation and European Journal of Clinical Pharmacology.

In The Last Decade

Gary L. C. Chan

14 papers receiving 317 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Gary L. C. Chan	85	81	75	59	50	14	327
L Öst	125 1.5×	144 1.8×	69 0.9×	54 0.9×	14 0.3×	15	450
U Frei	152 1.8×	51 0.6×	41 0.5×	64 1.1×	11 0.2×	40	482
B. Erbay	69 0.8×	42 0.5×	124 1.7×	32 0.5×	10 0.2×	20	401
David H. Van Buren	251 3.0×	79 1.0×	56 0.7×	85 1.4×	22 0.4×	19	439
John J. Rynasiewicz	196 2.3×	48 0.6×	106 1.4×	56 0.9×	49 1.0×	12	519
D Dahmane	83 1.0×	35 0.4×	93 1.2×	41 0.7×	8 0.2×	10	414
E Medina	67 0.8×	33 0.4×	160 2.1×	52 0.9×	19 0.4×	39	507
C R Shackleton	107 1.3×	33 0.4×	235 3.1×	24 0.4×	12 0.2×	25	556
D. Burgos	276 3.2×	105 1.3×	59 0.8×	83 1.4×	10 0.2×	43	533
B. Klare	201 2.4×	103 1.3×	45 0.6×	125 2.1×	7 0.1×	23	441

Countries citing papers authored by Gary L. C. Chan

Since Specialization

Citations

This map shows the geographic impact of Gary L. C. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary L. C. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary L. C. Chan more than expected).

Fields of papers citing papers by Gary L. C. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary L. C. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary L. C. Chan. The network helps show where Gary L. C. Chan may publish in the future.

Co-authorship network of co-authors of Gary L. C. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Gary L. C. Chan. A scholar is included among the top collaborators of Gary L. C. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary L. C. Chan. Gary L. C. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Wang, Xiaoxing, Madelyn Curto, Gary L. C. Chan, et al.. (2020). 15433 Assessment of cytochrome P450 3A inhibition and induction of abrocitinib: Midazolam drug-drug interaction (DDI) study and oral contraceptive DDI study. Journal of the American Academy of Dermatology. 83(6). AB151–AB151. 2 indexed citations

Chan, Gary L. C., et al.. (1998). Aortic Valve Replacement without Annular Enlargement in Patients with Small Aortic Roots. Asian Cardiovascular and Thoracic Annals. 6(4). 279–284. 1 indexed citations

Chan, Gary L. C., et al.. (1992). Drug interactions with cyclosporine: Focus on antimicrobial agents. Clinical Transplantation. 6(3pt1). 141–153. 1 indexed citations

Gruber, Scott A., Gary L. C. Chan, Daniel M. Canafax, & Arthur J. Matas. (1991). Immunosuppression in renal transplantation II. Corticosteroids, antilymphocyte globulin, and OKT3. Clinical Transplantation. 5(3). 219–232. 15 indexed citations

Chan, Gary L. C., Samuel Weinstein, Charles E. Wright, et al.. (1991). ENCEPHALOPATHY ASSOCIATED WITH OKT3 ADMINISTRATION. Transplantation. 52(1). 148–149. 20 indexed citations

Gruber, Saskia, Gary L. C. Chan, D. M. Canafax, & A. J. Matas. (1991). Immunosuppression in renal transplantation I. Cyclosporine and azathioprine. Clinical Transplantation. 5(2pt1). 65–85. 14 indexed citations

Chan, Gary L. C., Gary R. Erdmann, Scott A. Gruber, Arthur J. Matas, & Daniel M. Canafax. (1990). Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant Patients. The Journal of Clinical Pharmacology. 30(4). 358–363. 93 indexed citations

Canafax, Daniel M., Scott A. Gruber, Gary L. C. Chan, et al.. (1990). The Pharmacoeconomics of Renal Transplantation: Increased Drug Costs with Decreased Hospitalization Costs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 10(3). 205–210. 11 indexed citations

Chan, Gary L. C., et al.. (1990). Principles of Immunosuppression. Critical Care Clinics. 6(4). 841–892. 7 indexed citations

10.

Chan, Gary L. C., Gary R. Erdmann, S. A. Gruber, et al.. (1989). Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine. European Journal of Clinical Pharmacology. 36(3). 265–271. 17 indexed citations

11.

Chan, Gary L. C.. (1989). Alternative Dosing Strategy for Aminoglycosides: Impact on Efficacy, Nephrotoxicity, and Ototoxicity. DICP. 23(10). 788–794. 40 indexed citations

12.

Erdmann, Gary R., Gary L. C. Chan, & Daniel M. Canafax. (1988). HPLC Determination of 6-Thiouric Acid and 6-Mercaptopurine in Organ Transplant Patient Serum. Journal of Liquid Chromatography. 11(4). 971–981. 8 indexed citations

13.

Chan, Gary L. C., Daniel M. Canafax, & Curtis A. Johnson. (1987). The Therapeutic Use of Azathioprine in Renal Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 7(5). 165–177. 57 indexed citations

14.

Chan, Gary L. C. & Gary R. Matzke. (1987). Effects of Renal Insufficiency on the Pharmacokinetics and Pharmacodynamics of Opioid Analgesics. Drug Intelligence & Clinical Pharmacy. 21(10). 773–783. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact